-
LEO Pharma applies to EMA to expand Anzupgo use to adolescents
16 Dec 2025 10:47 GMT
… the US, and the UK.
LEO Pharma obtained exclusive development and commercialisation … Shionogi holds the rights.
LEO Pharma Development executive vice-president Sophie … label expansion application for Anzupgo, LEO Pharma is reinforcing our commitment aiming …
-
LEO Pharma Appoints Marika Murto to Lead Global Product Strategy
16 Dec 2025 08:45 GMT
… Leadership Team.
Marika joins LEO Pharma from Amgen, where … Murto will join LEO Pharma as Senior Vice President … 45 3050 2014
MailJEILK@leo-pharma.com
KEYWORD: DENMARK EUROPE … RESEARCH SCIENCE PHARMACEUTICAL
SOURCE: LEO Pharma
Copyright Business Wire 2025 …
-
<![CDATA[Top 5 Articles of the Week: December 14-19]]>
21 Dec 2025 15:26 GMT
… trials supporting delgocitinib cream (Anzupgo; LEO Pharma), the first and only FDA …
-
Vivian to represent LEO Pharma
23 Nov 2025 20:35 GMT
… partnered with global dermatology leader LEO Pharma to bring advanced skin treatments … dermatology.
“Our collaboration with LEO Pharma represents a major step forward … improvements.”
Paolo Pozzolini, general manager, LEO Pharma Italy, noted: “We chose Vivian …
-
LEO Pharma receives NICE approval for chronic hand eczema cream
10 Nov 2025 13:55 GMT
LEO Pharma has received Technology Appraisal Guidance ( … at LEO Pharma,” said Leanne Walsh, Vice President and General Manager, LEO Pharma UK …
-
LEO Pharma Delivers 8% Revenue Growth at CER in 9M 2025 and Updates Full-Year Outlook
06 Nov 2025 08:50 GMT
… with Boehringer Ingelheim closed, granting LEO Pharma global development and commercialization rights … for generalized pustular psoriasis. Leveraging LEO Pharma’s global dermatology platform, the … (1,262)
N.m.
About LEO Pharma
LEO Pharma is a global leader in …
-
LEO Pharma Strengthens Leadership in Medical Dermatology with the Appointment of Sophie Lamle as Chief Development Officer
03 Nov 2025 12:01 GMT
… strengthening LEO Pharma's Search & Development model.
Sophie joins LEO Pharma from … of the Innovation Committee.
About LEO Pharma
LEO Pharma is a global leader in … CLINICAL TRIALS OTHER HEALTH
SOURCE: LEO Pharma
Copyright Business Wire 2025.
PUB …
-
<![CDATA[LEO Pharma Finalizes Acquisition of Spesolimab for GPP]]>
03 Oct 2025 21:37 GMT
… the third strategic brand within LEO Pharma’s global dermatology portfolio.1 …
“With our specialization in dermatology, LEO Pharma is uniquely positioned to take … IL-36-mediated dermatoses.5
LEO Pharma will assume responsibility for commercialization …
-
LEO Pharma Presents Late-Breaking Results on Temtokibart for Atopic Dermatitis at EADV
18 Sep 2025 17:11 GMT
… Annual Meeting in Paris, France, LEO Pharma presented two late-breaking abstracts … advantages in specificity and safety. LEO Pharma has obtained a worldwide exclusive … , Science, Search & Innovation at LEO Pharma.
References
1. Weidinger S, et …
-
#EADV25: Leo Pharma details mid-stage win for IL-22 targeting antibody in atopic dermatitis
17 Sep 2025 14:19 GMT
About
© 1995-2025